Human Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020

Overview

Journal Pediatrics

Specialty Pediatrics

Date 2022 Jun 22

PMID 35730334

Authors

Peng-Jun Lu

David Yankey

Benjamin Fredua

Mei-Chun Hung

Natalie Sterrett

Lauri E Markowitz

Laurie D Elam-Evans

Affiliations

Soon will be listed here.

Abstract

Objective: To assess trends in recent human papillomavirus (HPV) vaccination initiation and factors associated with vaccination among adolescents.

Methods: The 2015 to 2020 National Immunization Survey-Teen data were used to assess vaccination trends. Multivariable logistic regression analysis were conducted to assess factors associated with vaccination.

Results: Overall, HPV vaccination coverage (≥1 dose) among adolescents significantly increased from 56.1% in 2015 to 75.4% in 2020. There were larger increases in coverage among males (4.7 percentage points annually) than females (2.7 percentage points annually) and coverage differences between males and females decreased in 2015 through 2020. Coverage in 2020 was 75.4% for adolescents aged 13 to 17 years; 73.7% for males and 76.8% for females (P < .05); 80.7% for those with a provider recommendation and 51.7% for those without (P < .05); and 80.3% for those with a well child visit at age 11 to 12 years, and 64.8% for those without (P < .05). Multivariable logistic regression results showed that main characteristics independently associated with a higher likelihood of vaccination included: a provider recommendation, age 16 to 17 years, non-Hispanic Black, Hispanic, or American Indian or Alaskan Native, Medicaid insurance, ≥2 provider contacts in the past 12 months, a well-child visit at age 11 to 12 years and having 1 or 2 vaccine providers (P < .05).

Conclusions: Overall, HPV vaccination coverage among adolescents increased during 2015 to 2020. Coverage increased faster among males than females and differences by sex narrowed during this time. Receiving a provider recommendation vaccination was important to increase vaccination coverage.

Citing Articles

"The big topic is COVID": A qualitative study about changes in HPV vaccine conversations between parents and primary care team members throughout the COVID-19 pandemic.

Llavona-Ortiz J, Van Scoy L, Fogel B, Pinto C, Graham J, Calo W Hum Vaccin Immunother. 2025; 21(1):2460844.

PMID: 39916438 PMC: 11810078. DOI: 10.1080/21645515.2025.2460844.

Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents.

Willis D, Narcisse M, James L, Selig J, Ason M, Scott A Clin Transl Sci. 2025; 18(1):e70042.

PMID: 39783703 PMC: 11713929. DOI: 10.1111/cts.70042.

Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling.

Brisson M, Laprise J, Drolet M, Chamberland E, Benard E, Burger E J Natl Cancer Inst Monogr. 2024; 2024(67):387-399.

PMID: 39529531 PMC: 11555275. DOI: 10.1093/jncimonographs/lgae038.

Association Between a Mother's Cervical Cancer Screening and Child's Human Papillomavirus (HPV) Vaccination Status.

Bloom A, Springer R, Angier H, Heintzman J, Likumahuwa-Ackman S, Huguet N Matern Child Health J. 2024; 28(12):2137-2146.

PMID: 39379736 PMC: 11790011. DOI: 10.1007/s10995-024-03998-0.

Associations of geographic-based socioeconomic factors and HPV vaccination among male and female children in five US states.

Xiong S, Humble S, Barnette A, Brandt H, Thompson V, Klesges L BMC Public Health. 2024; 24(1):702.

PMID: 38443823 PMC: 10916280. DOI: 10.1186/s12889-024-18206-5.

References

Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

Gust D, Darling N, Kennedy A, Schwartz B . Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008; 122(4):718-25. DOI: 10.1542/peds.2007-0538. View

Kreisel K, Spicknall I, Gargano J, Lewis F, Lewis R, Markowitz L . Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. Sex Transm Dis. 2021; 48(4):208-214. PMC: 10245608. DOI: 10.1097/OLQ.0000000000001355. View

Lu P, Yankey D, Fredua B, OHalloran A, Williams C, Markowitz L . Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States. J Pediatr. 2018; 206:33-41.e1. PMC: 6487492. DOI: 10.1016/j.jpeds.2018.10.034. View

Boyd E, Phillips J, Schoenberger Y, Simpson T . Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine. 2018; 36(28):4126-4133. DOI: 10.1016/j.vaccine.2018.04.085. View

. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. MMWR Morb Mortal Wkly Rep. 2013; 62(34):685-93. PMC: 4604993. View

Dorell C, Yankey D, Santibanez T, Markowitz L . Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011; 128(5):830-9. DOI: 10.1542/peds.2011-0950. View

. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57(40):1100-3. View

Gerend M, Weibley E, Bland H . Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009; 45(5):528-31. DOI: 10.1016/j.jadohealth.2009.02.006. View

10.

Lu P, Yankey D, Jeyarajah J, OHalloran A, Meyer S, Elam-Evans L . Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years. Am J Prev Med. 2017; 53(3):373-384. PMC: 5794009. DOI: 10.1016/j.amepre.2017.03.022. View

11.

Cataldi J, OLeary S, Markowitz L, Allison M, Crane L, Hurley L . Changes in Strength of Recommendation and Perceived Barriers to Human Papillomavirus Vaccination: Longitudinal Analysis of Primary Care Physicians, 2008-2018. J Pediatr. 2021; 234:149-157.e3. PMC: 10207027. DOI: 10.1016/j.jpeds.2021.03.002. View

12.

Hughes C, Jones A, Feemster K, Fiks A . HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011; 11:74. PMC: 3175168. DOI: 10.1186/1471-2431-11-74. View

13.

McClung N, Lewis R, Gargano J, Querec T, Unger E, Markowitz L . Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey. J Adolesc Health. 2019; 65(6):715-722. DOI: 10.1016/j.jadohealth.2019.07.003. View

14.

. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep. 1996; 45(RR-13):1-16. View

15.

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

16.

Elam-Evans L, Yankey D, Singleton J, Sterrett N, Markowitz L, Williams C . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020; 69(33):1109-1116. PMC: 7439984. DOI: 10.15585/mmwr.mm6933a1. View

17.

Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans L, Singleton J, Curtis C . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(29):784-92. PMC: 4584833. DOI: 10.15585/mmwr.mm6429a3. View

18.

Gilkey M, Calo W, Moss J, Shah P, Marciniak M, Brewer N . Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine. 2016; 34(9):1187-92. PMC: 4944755. DOI: 10.1016/j.vaccine.2016.01.023. View

19.

. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60(2):1-64. View

20.

. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60(50):1705-8. View